| 000 | 01309 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250514023637.0 | ||
| 264 | 0 | _c20020730 | |
| 008 | 200207s 0 0 eng d | ||
| 022 | _a0889-857X | ||
| 024 | 7 |
_a10.1016/s0889-857x(03)00073-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _avan de Loo, Fons A J | |
| 245 | 0 | 0 |
_aGene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators. _h[electronic resource] |
| 260 |
_bRheumatic diseases clinics of North America _cFeb 2002 |
||
| 300 |
_a127-49 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterleukin 1 Receptor Antagonist Protein |
| 650 | 0 | 4 |
_aInterleukin-10 _xgenetics |
| 650 | 0 | 4 |
_aInterleukin-4 _xgenetics |
| 650 | 0 | 4 |
_aSialoglycoproteins _xgenetics |
| 700 | 1 | _avan den Berg, Wim B | |
| 773 | 0 |
_tRheumatic diseases clinics of North America _gvol. 28 _gno. 1 _gp. 127-49 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0889-857x(03)00073-5 _zAvailable from publisher's website |
| 999 |
_c11749547 _d11749547 |
||